Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1-Reference-Cited by-同舟云学术

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

Published:2008-08 Issue:1-3 Volume:103 Page:104-109
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Meyer Jonathan M.,Davis Vicki G.,McEvoy Joseph P.,Goff Donald C.,Nasrallah Henry A.,Davis Sonia M.,Daumit Gail L.,Hsiao John,Swartz Marvin S.,Stroup T. Scott,Lieberman Jeffrey A.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference15 articles.

1. Consensus development conference on antipsychotic drugs and obesity and diabetes;American Diabetes Association;Journal of Clinical Psychiatry,2004

2. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women;Bansal;JAMA,2007

3. Balancing efficacy and safety in treatment with antipsychotics;Correll;CNS Spectrums,2007

4. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease;Eberly;Archives of Internal Medicine,2003

5. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE Study and matched controls;Goff;Schizophrenia Research,2005

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor: Weight gain and metabolic screening in young people with early psychosis on long acting injectable antipsychotic medication;Early Intervention in Psychiatry;2023-06-15

2. Special aspects in the pharmacotherapeutic treatment of forensically hospitalized female patients;Forensische Psychiatrie, Psychologie, Kriminologie;2023-04-21

3. Homocysteine Levels and Clinical Outcomes in Schizophrenia—A Pilot Randomized Controlled Trial;Journal of Pharmacology and Pharmacotherapeutics;2022-09

4. Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia;International Journal of General Medicine;2021-07

5. Management of Metabolic Syndrome in Schizophrenia;Psychiatric Annals;2020-08